下一篇Cure GAAP每股收益为-11.29美元

2025-08-09 02:04

NextCure press release (NASDAQ:NXTC): Q2 GAAP EPS of -$11.29.
Cash, cash equivalents, and marketable securities as of June 30, 2025 were $35.3 million as compared to $68.6 million as of December 31, 2024. The decrease of $33.3 million was primarily due to cash used to fund operations. We expect current financial resources to be sufficient to fund operating expenses and capital expenditures into mid-2026.

More on NextCure